BioSpace News Archive

Drug Development

B.More Submits FDA Investigational New Drug Application for Psilocybin Alcohol Use Disorder Program

B.More Inc, today announced the submission of an IND application to begin a Phase 2b trial to determine the efficacy and safety of synthetic psilocybin (SYNP-101) in treating alcohol use disorder (AUD).

July 25, 2022
·
2 min read
Pharm Country

New Olympus OEV321UH Monitor Brings Value, Expansion of 4K Offering and a Range of Compatibility Options for Endoscopy and Surgical Suites

Olympus announced the availability of a new monitor option, the OEV321UH video display monitor, a 32-inch Ultra High Definition 4K monitor that expands upon Olympus 4K monitor offerings.

July 25, 2022
·
2 min read
BioMidwest

Fresenius Kabi Expands Ready-to-Administer Portfolio with Glycopyrrolate Injection, USP Simplist® Prefilled Syringe

Fresenius Kabi announced today the immediate availability in the U.S. of Glycopyrrolate Injection, USP in 0.6 mg per 3 mL Simplist® ready-to-administer prefilled syringes.

July 25, 2022
·
6 min read
Business

Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor

Today, Enochian BioSciences (the Company) announced that Dr. Richard (Rich) Whitley, M.D., of the University of Alabama at Birmingham (UAB), will become the Company’s Senior Scientific Advisor.

July 25, 2022
·
2 min read
Business

American Diabetes Association Focuses on Prevention of Kidney Disease through Collaboration with DaVita

The American Diabetes Association® (ADA), along with DaVita, are excited to announce the launch of an interactive digital experience aimed at helping those living with diabetes prevent and manage kidney disease.

July 25, 2022
·
4 min read
LFB Announces the Approval of CEVENFACTA® (eptacog beta) in the European Union

LFB today announced that the European Medicines Agency (EMA) has granted on July 15th a Marketing Authorisation for CEVENFACTA® (eptacog beta), as the first new bypassing agent in over 20 years.

July 25, 2022
·
5 min read
Business

NEUVOGEN Appoints Stephen A. Sherwin, M.D. to its Scientific Advisory Board

NEUVOGEN, an immuno-oncology company with a next-generation cancer vaccine platform, is pleased to announce the appointment of Stephen A. Sherwin, M.D., to the company’s Scientific Advisory Board (SAB).

July 25, 2022
·
3 min read
Acne Treatment Market Research by Expert: Growth Rate, Industry Statistics and Forecasts to 2030

Forecast to 2030,’ thoroughly examines the Acne Treatment industry to provide essential data & information for the targeted readers.

July 25, 2022
·
5 min read
Anaphylaxis Treatment Market Upcoming Trends, Growth Analysis, Business Overview and Forecast - 2030

Forecast to 2030,’ thoroughly examines the Anaphylaxis Treatment industry to provide essential data & information for the targeted readers.

July 25, 2022
·
5 min read
Ataxia Treatment Market: Strategic Analysis to Understand Competitive Outlook for the Industry till 2030

Forecast to 2030,’ thoroughly examines the Ataxia Treatment industry to provide essential data & information for the targeted readers.

July 25, 2022
·
6 min read